Extended-spectrum beta-lactamase-producing Enterobacteriaceae at Middlemore Hospital

New Zealand Medical Journal

Volumn 118, Issue 1218, 2005, Pages

  Briggs, Simon ^a,b   Ussher, James ^a   Taylor, Susan ^a  

^a MIDDLEMORE HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFACLOR; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; ERTAPENEM; FLUCLOXACILLIN; GENTAMICIN; IMIPENEM; MEROPENEM; MOXIFLOXACIN; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BLOOD; CHILD; CONTROLLED STUDY; ENTEROBACTER; ENTEROBACTER CLOACAE; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; HOSPITAL ADMISSION; HUMAN; KLEBSIELLA PNEUMONIAE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NONHUMAN; RESIDENTIAL CARE; REVIEW; ARTICLE; BACTEREMIA; BIOSYNTHESIS; ENZYMOLOGY; HOSPITALIZATION; INFANT; INTENSIVE CARE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; LONG-TERM CARE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEW ZEALAND;

EID: 26944449064     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Knothe H, Shah P, Krcmery V et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983; 11: 315-7.
2. Anonymous. Extended-spectrum beta-lactamase in Enterobacteriaceae. LabLink, Institute of Environmental Science and Research Limited; 1994; 1:6.
3. Institute of Environmental Science and Research Limited. Extended-spectrum beta-lactamases in Enterobacteriaceae confirmed in 2003. Wellington: Institute of Environmental Science and Research Limited; 2004. Available online. URL: http://www.surv.esr.cri.nz/antimicrobial/esbl.php Accessed July 2005.
4. NCCLS. Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth Informational Supplement. NCCLS document M100-S14 (ISBN 1-56238-516-X). NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA; 2004.
5. Livermore DM, Woodford N. Laboratory detection and reporting of bacteria with extended-spectrum beta-lactamases. Health Protection Agency document. London: Health Protection Agency; 2004.
6. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10:867-78.
7. Sturenburg E, Mack D. Extended-spectrum beta-Lactamases: implications for the clinical microbiology laboratory, therapy and infection control. J Infect. 2003;47:273-95.
8. Poirel L, Lebessi E, Castro M et al. Nosocomial outbreak of extended-spectrum beta-lactamase SHV-5-producing isolates of Pseudomonas aeruginosa in Athens, Greece. Antimicrob Agents Chemother. 2004;48:2277-9.
9. Vahaboglu H, Ozturk R, Aygun G et al. Widespread detection of PER- 1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother. 1997;41:2265-9.
10. Paterson DL, Ko WC, Von Gottberg A et al. Antibiotic therapy for Klebsiella pneumoniae bacteraemia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis. 2004;39:31-7.
11. Livermore DM, Sefton AM, Scott GM. Properties and potential of ertapenem. J Antimicrob Chemother. 2003;52:331-44.
12. Endimiani A, Luzzaro F, Perilli M, et al. Bacteraemia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin. Clin Infect Dis. 2004;38:243-51.
13. Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Clin Microbiol Infect. 2000;6:460-3.
14. Du B, Long Y, Liu H et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med. 2002;28:1718-23.
15. Menashe G, Borer A, Yagupsky P, et al. Clinical significance and impact on mortality of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates in nosocomial bacteraemia. Scand J Infect Dis. 2001;33:188-93.
16. Bradford PA. Extended-spectrum beta-lactamases of the 21st century: characterisation epidemiology and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-51.
17. Rasmussen BA, Bradford PA, Quinn JP et al. Genetically diverse ceftazidime-resistant isolates from a single centre: biochemical and genetic characterisation of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother. 1993;37:1989-92.
18. Weiner J, Quinn JP, Bradford PA et al. Multiple antibiotic-resistant Klebsietta and Escherichia coli in nursing homes. JAMA. 1999;281:517-23.
19. Colodner R, Rock W, Chazan B et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalised patients. Eur J Clin Microbiol Infect Dis. 2004;23:163-7.
20. Rodriguez-Bano J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalised patients. J Clin Microbiol. 2004;42:1089-94.
21. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pnellmoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Centre. Clin Infect Dis. 1996;23:118-24.